ALISKIREN HEMIFUMARATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Aliskiren Hemifumarate, and when can generic versions of Aliskiren Hemifumarate launch?
Aliskiren Hemifumarate is a drug marketed by Anchen Pharms and is included in one NDA.
The generic ingredient in ALISKIREN HEMIFUMARATE is aliskiren hemifumarate. There are four drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the aliskiren hemifumarate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Aliskiren Hemifumarate
A generic version of ALISKIREN HEMIFUMARATE was approved as aliskiren hemifumarate by ANCHEN PHARMS on March 22nd, 2019.
Summary for ALISKIREN HEMIFUMARATE
Pharmacology for ALISKIREN HEMIFUMARATE
Drug Class | Renin Inhibitor |
Mechanism of Action | Renin Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for ALISKIREN HEMIFUMARATE
Paragraph IV (Patent) Challenges for ALISKIREN HEMIFUMARATE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
TEKTURNA | Tablets | aliskiren hemifumarate | 150 mg and 300 mg | 021985 | 1 | 2014-01-27 |
US Patents and Regulatory Information for ALISKIREN HEMIFUMARATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anchen Pharms | ALISKIREN HEMIFUMARATE | aliskiren hemifumarate | TABLET;ORAL | 206665-001 | Mar 22, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Anchen Pharms | ALISKIREN HEMIFUMARATE | aliskiren hemifumarate | TABLET;ORAL | 206665-002 | Mar 22, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |